As pharmaceutical companies reorient their commercialization strategies around modernized and human-centered design, they need to account for more factors than ever—not only the need to engage with the holistic patient, but also the people who support their care: family members, healthcare providers, advocacy groups, and others. 

But how? Learn how Teun Schutte (Hexaware Life Sciences) and Mark de Leeuw (Rhythm Pharmaceuticals) utilized human-centered design to navigate these and other post-launch engagement considerations. Exploring a patient engagement model built for a rare childhood disease as an example, Schutte and de Leeuw will discuss:

• How and why demands surrounding patient engagement are changing
• Opportunities to transform engagement strategies through a tech- and people-powered lens
• Strategies to address gaps throughout the patient journey
• Noteworthy focus areas where digital transformation offers particular opportunity and competitive advantage